Cerebramine tablets, 155 mg 40 pcs

The pathology of the central nervous system most frequently develops after injuries, infections, autoimmune, vascular and metabolic diseases and is accompanied by a significant reduction in the quality of life of patients.

The polymorphism of clinical and morphological manifestations of brain pathology is largely determined by features of neurophysiological changes at different levels of integrative brain activity, which, in turn, depend on genetic and phenotypic predisposition to brain diseases.

All reactions arising after cerebral lesions are considered as a set of pathological and compensatory-adaptive processes occurring with a certain periodicity.

The etiopathogenetic factors contributing to the development of diseases of cerebral structures are diverse, so for the correction and prevention of brain dysfunctions occurring in various diseases, Cerebramine has been developed.

• It has a selective effect on brain cells and normalizes its functions, improves memory and attention, provides prevention of possible cerebral circulatory disorders and their consequences.
• Accelerates recovery of brain functions after brain trauma, stroke, brain surgery, cerebral palsy, learning disabilities, delayed psychomotor and speech development in children, intellectual and mental disorders.
• It is recommended in cases of intense mental activity, as well as for the elderly.

The components for “Cerebramine”, derived from the cerebral cortex of cattle, is a complex of proteins and nucleoproteins, having a selective effect on the brain cells, which helps accelerate the restoration of various brain functions and normalization of mnemonic processes.

The clinical trials of “Cerebramine” were conducted with the participation of 270 patients with distant consequences of craniocerebral injuries of different ages, consequences of acute violations of cerebral circulation, discirculatory encephalopathy and intellectual and mental disorders.

The efficacy of “Cerebramine” was evaluated on the basis of the dynamics of subjective complaints and objective indices of laboratory and instrumental studies, as well as special test methods of monitoring the state of the psycho-emotional sphere of the patients.

When assessing the subjective state of the patients against the background of taking “Cerebramine” we found a significant reduction in complaints of a general and asthenic nature. The patients experienced normalization of mnemonic processes, including short-term memory, improvement of situational awareness and restoration of professional skills.

It was characteristic that against the background of taking “Cerebramine” the severity of asthenic and asthenovegetative syndromes decreased rapidly, psychoemotional state, attention and mental performance improved. It was found that after a course of consumption of “Cerebramine” stabilization of bioelectrical activity of the brain and improvement of the structure of the electroencephalogram were observed in the patients.

Thus, optimization of the functions of the cerebral cortex against the background of a course of administration of “Cerebramine” promotes normalization of integrative activity of the brain and reduces manifestations of intellectual and mental deficit.

“Cerebramine” is recommended for acceleration of cerebral function restoration after stroke, craniocerebral injury, cerebral surgery, pediatric cerebral palsy, learning disabilities, delayed psychomotor and speech development in children, intellectual and mental disorders, the impact of various extreme factors on the body.

The use of “Cerebramine” is recommended for the elderly to maintain optimal brain function. Long-term experience of using Cerebramine showed that it is successfully used by students during examinations as well as by the employees of the banking sphere.

Indications

• Acute and chronic insufficiency of cerebral circulation
• consequences of craniocerebral injuries;
• dyscirculatory encephalopathy;
• sequelae of neuroinfections;
• demyelinating diseases of the central nervous system;
• vegetative dysfunction;
• pre- and postoperative periods for neurosurgical surgeries;
• states after extreme stress loads.

.

Composition

Cerebramine powder (complex of polypeptides and nucleic acids derived from the brain of bovine cattle) – 10 mg,

sucrose (lactose),

calcium stearate,

intestinal coating.

How to take, the dosage

Take 1-3 tablets 2-3 times a day 10-15 minutes before a meal with water, without chewing.

Course: 10-14 days.

Repeat course in 3-6 months.

Contraindications

Individual intolerance to the components of the product, pregnancy, breast-feeding.